|
ZA989389B
(en)
*
|
1997-11-14 |
2000-04-14 |
Lilly Co Eli |
Pyrrolo [3,2-b] pyridine processes and intermediates.
|
|
US5905084A
(en)
*
|
1997-11-14 |
1999-05-18 |
Eli Lilly And Company |
5-HTIF -agonists effective in treating migraine
|
|
US6133290A
(en)
*
|
1998-07-31 |
2000-10-17 |
Eli Lilly And Company |
5-HT1F agonists
|
|
GB9823845D0
(en)
*
|
1998-11-02 |
1998-12-23 |
Lilly Co Eli |
Pharmaceutical compounds
|
|
US6608079B1
(en)
|
1998-12-11 |
2003-08-19 |
Eli Lilly And Company |
Indole derivatives and their use as 5-HT1F agonists
|
|
US7998986B2
(en)
|
2001-12-21 |
2011-08-16 |
Exelixis Patent Company Llc |
Modulators of LXR
|
|
US7482366B2
(en)
|
2001-12-21 |
2009-01-27 |
X-Ceptor Therapeutics, Inc. |
Modulators of LXR
|
|
TWI263497B
(en)
*
|
2002-03-29 |
2006-10-11 |
Lilly Co Eli |
Pyridinoylpiperidines as 5-HT1F agonists
|
|
ES2201899B1
(es)
*
|
2002-04-01 |
2005-06-01 |
Almirall Prodesfarma, S.A. |
Derivados de la azaindolilpiperidina como agentes antihistaminicos y antialergicos.
|
|
BRPI0409211A
(pt)
|
2003-04-18 |
2006-03-28 |
Lilly Co Eli |
composto, composição farmacêutica, métodos para ativar receptores 5-ht1f, para inibir extravasão de proteìna neuronial, e para o tratamento ou prevenção de enxaqueca em um mamìfero, e, uso de um composto
|
|
UA82711C2
(en)
|
2003-09-12 |
2008-05-12 |
Эли Лилли Энд Компани |
Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-ht1f agonists
|
|
EP1684694A2
(en)
*
|
2003-11-21 |
2006-08-02 |
Array Biopharma, Inc. |
Akt protein kinase inhibitors
|
|
WO2005061439A1
(en)
|
2003-12-17 |
2005-07-07 |
Eli Lilly And Company |
Substituted (4-aminocyclohexen-1-yl)phenyl and (4-aminocyclohexen-1-yl)pyridinyl compounds as 5-ht1f agonists
|
|
DE602007011628D1
(de)
|
2006-07-06 |
2011-02-10 |
Array Biopharma Inc |
Dihydrofuropyrimidine als akt-proteinkinaseinhibitoren
|
|
CA2656618C
(en)
*
|
2006-07-06 |
2014-08-26 |
Array Biopharma Inc. |
Cyclopenta [d] pyrimidines as akt protein kinase inhibitors
|
|
US8063050B2
(en)
|
2006-07-06 |
2011-11-22 |
Array Biopharma Inc. |
Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
|
|
EP2054418B1
(en)
|
2006-07-06 |
2011-11-09 |
Array Biopharma Inc. |
Dihydrothieno pyrimidines as akt protein kinase inhibitors
|
|
US8846683B2
(en)
|
2007-07-05 |
2014-09-30 |
Array Biopharma, Inc. |
Pyrimidyl cyclopentanes as Akt protein kinase inhibitors
|
|
ES2533557T3
(es)
*
|
2007-07-05 |
2015-04-13 |
Array Biopharma, Inc. |
Pirimidil ciclopentanos como inhibidores de proteína cinasa AKT
|
|
AR067413A1
(es)
|
2007-07-05 |
2009-10-07 |
Genentech Inc |
Compuestos heterociclicos que contienen ciclopenta[d]pirimidina inhibidores de proteinquinasas akt, composiciones farmaceuticas que los contienen, metodo de preparacion y uso de las mismas para el tratamiento de enfermedades hiperproliferativas, tales como cancer
|
|
US9409886B2
(en)
|
2007-07-05 |
2016-08-09 |
Array Biopharma Inc. |
Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
|
|
WO2009089459A1
(en)
*
|
2008-01-09 |
2009-07-16 |
Array Biopharma Inc. |
Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
|
|
MX2010007546A
(es)
*
|
2008-01-09 |
2010-09-30 |
Array Biopharma Inc |
Pirimidil ciclopentanos hidroxilados en forma de inhibidores de akt proteína quinasa.
|
|
MX2011010359A
(es)
|
2009-04-02 |
2012-02-23 |
Colucid Pharmaceuticals Inc |
Composición de 2,4,6-trifluoro-n-[6-(1-metilo-piperidina-4-carboni lo)-piridina-2-ilo]-benzamida.
|
|
US8697876B2
(en)
|
2010-04-02 |
2014-04-15 |
Colucid Pharmaceuticals, Inc. |
Compositions and methods of synthesis of pyridinolypiperidine 5-HT1F agonists
|
|
CN103841976A
(zh)
|
2011-04-01 |
2014-06-04 |
基因泰克公司 |
Akt和mek抑制剂化合物的组合及其使用方法
|
|
CN103841975A
(zh)
|
2011-04-01 |
2014-06-04 |
基因泰克公司 |
Akt抑制剂化合物和厄洛替尼的组合以及使用方法
|
|
BG111544A
(bg)
|
2013-07-29 |
2015-01-30 |
Николай Цветков |
Субституирани бензамидни производни като in vitro mao-b инхибитори
|
|
LT3027603T
(lt)
*
|
2013-08-02 |
2018-08-10 |
Pfizer Inc. |
Heterobicikloarilo rorc2 inhibitoriai ir jų panaudojimo būdai
|
|
MA40759A
(fr)
|
2014-09-26 |
2017-08-01 |
Pfizer |
Modulateurs de rorc2 de type pyrrolopyridine substitué par un méthyle et trifluorométhyle et leurs procédés d'utilisation
|
|
PL3416964T3
(pl)
*
|
2016-02-19 |
2021-10-18 |
Phoenix Molecular Designs |
Pochodne 6-okso-n-(1-(benzylo)-1h-pirazol-4-ilo)-6,7,8,9-tetrahydropirydo[3’,2’:4,5]pirolo[1,2-a]pirazyno-2-karboksyamidu jako inhibitory kinazy rybosomalnej s6 p90 (rsk) do leczenia nowotworu złośliwego
|
|
CA3107145A1
(en)
|
2018-08-24 |
2020-02-27 |
Sunshine Lake Pharma Co., Ltd. |
Pyridinylmethylenepiperidine derivatives and uses thereof
|
|
TWI826514B
(zh)
|
2018-09-04 |
2023-12-21 |
美商美國禮來大藥廠 |
用於預防偏頭痛之拉米迪坦(lasmiditan)長期夜間投藥
|
|
CN113677681A
(zh)
|
2019-02-11 |
2021-11-19 |
凤凰分子设计公司 |
Rsk抑制剂的结晶形式
|
|
TWI829107B
(zh)
|
2019-07-09 |
2024-01-11 |
美商美國禮來大藥廠 |
大規模製備2,4,6-三氟-n-[6-(1-甲基-哌啶-4-羰基)-吡啶-2-基]-苯甲醯胺半琥珀酸鹽的方法及中間體，以及2,4,6-三氟-n-[6-(1-甲基-哌啶-4-羰基)-吡啶-2-基]-苯甲醯胺醋酸鹽之製備
|